Safety, Tolerability and Efficacy Study of PP1420 in HV

NCT02221765 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

49

Enrollment

OTHER

Sponsor class

Stopped Expected PK\&no safety issues in 1B.1Cwon't proceed due to lack of 1Befficacy

Conditions

Obesity

Interventions

DRUG: PP1420
DRUG: Placebo

Sponsor

Imperial College London

Collaborators

[object Object]
[object Object]